Archetypical Patterns of Skin Manifestations in Neurocutaneous Disorders

Martino Ruggieri; Andrea D. Praticò; Francesco Lacarrubba; Giuseppe Micali; Carmelo Schepis; Agata Polizzi

doi:10.1055/s-0038-1667067

Journal of Pediatric Neurology, Table of Contents

Journal of Pediatric Neurology 2018; 16(05): 255-264
DOI: 10.1055/s-0038-1667067

Review Article

Georg Thieme Verlag KG Stuttgart · New York

Archetypical Patterns of Skin Manifestations in Neurocutaneous Disorders

Martino Ruggieri

¹Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Italy

,

Andrea D. Praticò

¹Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Italy

,

Francesco Lacarrubba

²Dermatology Clinic, University of Catania, Catania, Italy

,

Giuseppe Micali

²Dermatology Clinic, University of Catania, Catania, Italy

,

Carmelo Schepis

³Unit of Dermatology, Oasi Research Institute-IRCCS, Troina, Enna, Italy

,

Agata Polizzi

⁴Institute of Neurological Sciences, National Research Council, Catania, Italy

› Author Affiliations

Abstract

The distribution of the cutaneous manifestations in neurocutaneous disorders is not casual; rather, it reflects predetermined patterns of skin arrangements, due to the action of the underlying genes, proteins, and/or metabolic pathways on the skin texture and appendages. These patterns of distribution are pathognomonic for each neurocutaneous disorder and can occur either in specific areas of the body (e.g., the forehead, the face, the trunk, the nails, one limb or one of more segments of the body) or following specific lines (e.g., lines of Blaschko) or taking peculiar shapes (e.g., leaf-like, ovoid, whorled, “S” or “V” shaped). These patterns of abnormal skin often mirror similar phenomena in extra-cutaneous organs/tissues, principally in the central nervous system but also in the eye, bone, heart/vessels, lung, kidney, and gut. A classification system, including several patterns of cutaneous arrangements (archetypical patterns) was proposed by the German dermatologist Rudolf Happle in 1993 and later expanded until 2014: this classification, originally meant to broadly explain (genetic and nongenetic) mosaic skin disorders and phenomena, was later expanded to explain the patterns of distribution of skin manifestations in some autosomal dominant skin disorders (genodermatoses). Currently, we recognize: (1) six archetypical patterns, including type 1 “along the lines of Blaschko” in (a) narrow or (b) large bands, type 2 “checkerboard” pattern, type 3 “phylloid” pattern, type 4 “patchy pattern without midline separation,” type 5 “lateralization” pattern, and type 6 “sash-like” pattern; (2) three less well-defined (so far unclassifiable) archetypical patterns, including (a) a diffuse hypopigmentation of the trunk versus smaller areas of normal skin on a unilateral aspect of the thorax and a segmental hyperpigmentation involving both arms and the trunk, (b) an “atypical” pattern along the Blaschko's lines, (c) the “mesotropic facial pattern,” and (iii) segmental manifestations of monogenic disorders, including (type 1) segmental areas of skin affected with the typical manifestations of a disease associated to otherwise unaffected skin and (type 2) segmental areas of skin affected with a very pronounced degree of the typical skin manifestations of a disease. In this article we review the existing literature on the early history of Blaschko's lines, the presentation of the (well-defined and unclassified) archetypical patterns and the segmental manifestations of monogenic disorders tailoring these concepts to neurocutaneous disorders.

Keywords

archetypical - Blaschko lines - phylloid pattern - checkboard pattern - lateralized pattern - sash-like pattern - neurocutaneous disorders

Full Text

References

References
1 Ruggieri M, Pascual-Castroviejo I, Di Rocco C. Neurocutaneous disorders. Phakomatoses and Hamartoneoplastic Syndromes. New York/Wien: Springer Verlag; 2008
2 Islam MP, Roach ES. Neurocutaneous syndromes. Handbook of Clinical Neurology: 3rd Series. No. 132. Amsterdam, Oxford, New York: Elsevier; 2015
3 van Steensel MA. Neurocutaneous manifestations of genetic mosaicism. J Pediatr Genet 2015; 4 (03) 144-153
4 Ruggieri M, Praticò AD. Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol 2015; 22 (04) 207-233
5 Nathan N, Keppler-Noreuil KM, Biesecker LG, Moss J, Darling TN. Mosaic disorders of the PI3K/PTEN/AKT/TSC/mTORC1 signaling pathway. Dermatol Clin 2017; 35 (01) 51-60
6 Lim YH, Moscato Z, Choate KA. Mosaicism in cutaneous disorders. Annu Rev Genet 2017; 51: 123-141
7 Happle R. Mosaicism in human skin. Understanding Nevi, Nevoid Skin Disorders, and Cutaneous Neoplasia. Berlin/Heidelberg: Springer-Verlag; 2014
8 Ranieri C, Di Tommaso S, Loconte DC. , et al. In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS). Neurogenetics 2018; 19 (02) 77-91
9 Happle R. Mosaicism in human skin. Understanding the patterns and mechanisms. Arch Dermatol 1993; 129 (11) 1460-1470
10 Happle R. Pigmentary patterns associated with human mosaicism: a proposed classification. Eur J Dermatol 1993; 3: 170-174
11 Happle R. Dohi Memorial Lecture. New aspects of cutaneous mosaicism. J Dermatol 2002; 29 (11) 681-692
12 Happle R. How frequently does genetic mosaicism occur in the skin?. Hautarzt 2014; 65 (06) 536-541
13 Happle R. Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet 1996; 66 (02) 241-242
14 Happle R. A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 1997; 133 (12) 1505-1509
15 Unsigned. Alfred Blaschko. 2018. Available at: http://whonamedit.com . Accessed December 18, 2017
16 Jackson R. The lines of Blaschko: a review and reconsideration: Observations of the cause of certain unusual linear conditions of the skin. Br J Dermatol 1976; 95 (04) 349-360
17 Bolognia JL, Orlow SJ, Glick SA. Lines of Blaschko. J Am Acad Dermatol 1994; 31 (2 Pt 1): 157-190 , quiz 190–192
18 Yazdani Abyaneh MA, Griffith R, Falto-Aizpurua L, Nouri K. Famous lines in history: Blaschko lines. JAMA Dermatol 2014; 150 (10) 1062
19 Blaschko A. Der Nervenverteilung in der Haut ihrer Bezielung zu den Erkrankungen der Haut. Beilage zu den Verhandlungen der Deutschen Dermatologischen Gesellschaft. VII Congress zu Breslau im Mai 1901. Wien und Leipzig: Wilhelm Braumüller; 1901
20 Happle R, Fuhrmann-Rieger A, Fuhrmann W. How are the Blaschko lines arranged on the scalp?. Hautarzt 1984; 35 (07) 366-369
21 Happle R. Absence of bipolarity in Blaschko's lines. Ann Dermatol Venereol 1990; 117 (05) 397
22 Alexander A. Ein Fall von Naevus linearis (Ichtyosis linearis) unius lateris. Dermatol Zeitschr 1895; 2: 343-36121
23 Blaschko A. Benerkungen zu vorstehendem Aufsatz. Dermatol Zeitscher. [Alexander A. Ein Fall von Naevus linearis (Ichtyosis linearis) unius lateris. Dermatol Zeitschr 1895; 2: 343–361] Dermatol Zeitschr 1895; 2: 361-372
24 Montgomery DW. The cause of the streaks in neavus linearis. J Cutan Genitourin Dis 1901; 19: 455-464
25 Montgomery DW. The cause of the streaks in nevus linearis. 1901. Arch Dermatol 2001; 137 (10) 1291
26 Siegel DH. Cutaneous mosaicism: a molecular and clinical review. Adv Dermatol 2008; 24: 223-244
27 Senear FE, Caro MR. Lichen striatus. Arch Dermatol Syphilol 1941; 43: 116-133
28 Haensch R. Eczema and neural factors. Observations in polyneuroradiculitis[article in German]. Arch Klin Exp Dermatol 1961; 214: 35-40
29 Toendury G. Embryology and skin topography. Arch Klin Exp Dermatol 1964; 219: 12-24
30 Alfonso-Trujillo I, Arteaga-Hernández E, Pérez-Suárez JC. Eccrine spiradenoma in a zosteriform distribution: presentation of a case [article in Spanish]. Actas Dermosifiliogr 2009; 100 (07) 619-620
31 Elston DM. Zosteriform distribution of acantholytic dyskeratotic epidermal nevus?. J Am Acad Dermatol 1999; 40 (04) 647
32 Engelman DE, Kotz III EA, Maize Sr JC. Linear cutaneous lupus erythematosus in the lines of Blaschko. Pediatr Dermatol 2007; 24 (02) 125-129
33 Englander L, Emer JJ, McClain D, Amin B, Turner RB. A rare case of multiple segmental eccrine spiradenomas. J Clin Aesthet Dermatol 2011; 4 (04) 38-44
34 Yoshida A, Takahashi K, Maeda F, Akasaka T. Multiple vascular eccrine spiradenomas: a case report and published work review of multiple eccrine spiradenomas. J Dermatol 2010; 37 (11) 990-994
35 Macdonald RH, Sims RT. Linear lesions. Br J Dermatol 1969; 81: 3 , 72–79
36 Carol WLL. Leerboek der Huidziekten. Amsterdam: Scheltema & Holkema's Boekhandel en Uitgeversmaatschappij; 1944
37 Siemens HW. Algemene Dermatologie: Diagnostiek en Therapie. Amsterdam: Scheltema & Holkema's Boekhandel en Uitgeversmaatschappij; 1948
38 Siemens HW. Algemene Dermatologie: Diagnostiek en Therapie der Hautkrankheiten: als Einfuhrung in die Dermatologie für Studierende und Praktiker. Berlin: Springer; 1952
39 Curth HO, Warburtno D. The genetics of incontinentia pigmenti. Arch Dermatol 1965; 92: 229-235
40 Happle R. Genetic significance of Blaschko's lines [article in German]. Z Hautkr 1977; 52 (18) 935-944
41 Happle R. Genetic interpretation of linear skin abnormalities [article in German]. Hautarzt 1978; 29 (07) 357-363
42 Happle R. The lines of Blaschko: a developmental pattern visualizing functional X-chromosome mosaicism. Curr Probl Dermatol 1987; 17: 5-18
43 Lenz W. Medizinische Genetik: Grundlagen, Ergebnisse und Probleme. 2nd ed. Stuttgart: Thieme; 1970
44 Lenz W. Letter: Half chromatid mutations may explain incontinentia pigmenti in males. Am J Hum Genet 1975; 27 (05) 690-691
45 Happle R, Assim A. The lines of Blaschko on the head and neck. J Am Acad Dermatol 2001; 44 (04) 612-615
46 Moss C, Savin J. Dermatology and the new genetics. Oxford: Blackwell Science Ltd; 1995
47 Moss C. Cytogenetic and molecular evidence for cutaneous mosaicism: the ectodermal origin of Blaschko lines. Am J Med Genet 1999; 85 (04) 330-333
48 Ruggieri M, Magro G, Ruggieri M, Polizzi A. Tumors and hypomelanosis of Ito. Arch Pathol Lab Med 2001; 125 (05) 599-601
49 Gilmore S, Maini P. Viewpoint 3 in: what is the biological basis of pattern formation in skin lesions?. Exp Dermatol 2006; 15: 557-559
50 Cattanach BM, Wolfe HG, Lyon MF. A comparative study of the coats of chimaeric mice and those of heterozygotes for X-linked genes. Genet Res 1972; 19 (03) 213-228
51 Mintz B. Gene control of mammalian pigmentary differentiation. I. Clonal origin of melanocytes. Proc Natl Acad Sci U S A 1967; 58 (01) 344-351
52 Kucera GT, Bortner DM, Rosenberg MP. Overexpression of an Agouti cDNA in the skin of transgenic mice recapitulates dominant coat color phenotypes of spontaneous mutants. Dev Biol 1996; 173 (01) 162-173
53 Cattanach BM. Finding the gene for brindle. Boxer Ring 2005; 2: 28-32
54 Happle R. Transposable elements and the lines of Blaschko: a new perspective. Dermatology 2002; 204 (01) 4-7
55 Kerns JA, Cargill EJ, Clark LA. , et al. Linkage and segregation analysis of black and brindle coat color in domestic dogs. Genetics 2007; 176 (03) 1679-1689
56 Ruggieri M, Pavone L. Hypomelanosis of Ito: clinical syndrome or just phenotype?. J Child Neurol 2000; 15 (10) 635-644
57 Ruggieri M, Tigano G, Mazzone D, Tiné A, Pavone L. Involvement of the white matter in hypomelanosis of Ito (incontinentia pigmenti achromiens). Neurology 1996; 46 (02) 485-492
58 Pavone P, Praticò AD, Ruggieri M, Falsaperla R. Hypomelanosis of Ito: a round on the frequency and type of epileptic complications. Neurol Sci 2015; 36 (07) 1173-1180
59 Pavone V, Signorelli SS, Praticò AD. , et al. Total hemi-overgrowth in pigmentary mosaicism of the (hypomelanosis of Ito) Ito type: eight case reports. Medicine (Baltimore) 2016; 95 (10) e2705
60 Ruggieri M. Familial hypomelanosis of ito: implications for genetic counseling. Am J Med Genet 2000; 95 (01) 82-84
61 Pavone P, Praticò AD, Gentile G. , et al. A neurocutaneous phenotype with paired hypo and hyperpigmented macules, microcephaly and stunted growth as prominent features. Eur J Med Genet 2016; 59 (05) 283-289
62 Babilas P, Schreml S, Landthaler M, Vogt T. A 12-month-old boy with impaired pigmentation. Diagnosis: nevus depigmentosus. Pediatr Ann 2009; 38 (11) 617-621
63 Findlay GH, Moores PP. Pigment anomalies of the skin in the human chimaera: their relation to systematized naevi. Br J Dermatol 1980; 103 (05) 489-498
64 Fitzgerald PH, Donald RA, Kirk RL. A true hermaphrodite dispermic chimera with 46,XX and 46,XY karyotypes. Clin Genet 1979; 15 (01) 89-96
65 Torchia D, Happle R. Segmental hypomelanosis and hypermelanosis arranged in a checkerboard pattern are distinct naevi: flag-like hypomelanotic naevus and flag-like hypermelanotic naevus. J Eur Acad Dermatol Venereol 2015; 29 (11) 2088-2099
66 Happle R. Phylloid hypomelanosis is closely related to mosaic trisomy 13. Eur J Dermatol 2000; 10 (07) 511-512
67 Schepis C, Failla P, Siragusa M, Romano C. An additional case of macular phylloid mosaicism. Dermatology 2001; 202 (01) 73
68 Faletra F, Berti I, Tommasini A. , et al. Phylloid pattern of hypomelanosis closely related to chromosomal abnormalities in the 13q detected by SNP array analysis. Dermatology 2012; 225 (04) 294-297
69 Happle R, Franco-Guío MF, Santacoloma-Osorio G. Phylloid hypermelanosis: a cutaneous marker of several different disorders?. Pediatr Dermatol 2014; 31 (04) 504-506
70 Oiso N, Sakai K, Nishio K, Kawada A. Phylloid hypomelanosis associated with a mosaic trisomy 13 in the 13q31.3-qter region: atypical phylloid distribution and typical hypomelanosis. Pigment Cell Melanoma Res 2017; 30 (02) 269-272
71 Happle R. Giant melanocytic nevus may be explained as a superimposed patchy manifestation of a polygenic trait. Dermatology 2010; 221 (01) 30-33
72 Kinsler VA, Thomas AC, Ishida M. , et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 2013; 133 (09) 2229-2236
73 König A, Happle R, Bornholdt D, Engel H, Grzeschik KH. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet 2000; 90 (04) 339-346
74 König A, Happle R, Fink-Puches R. , et al. A novel missense mutation of NSDHL in an unusual case of CHILD syndrome showing bilateral, almost symmetric involvement. J Am Acad Dermatol 2002; 46 (04) 594-596
75 Happle R. Phacomatosis pigmentokeratotica is a “pseudodidymosis”. J Invest Dermatol 2013; 133 (08) 1923-1925
76 Ruggieri M. Cutis tricolor: congenital hyper and hypopigmented lesions in a background of normal skin with and without associated systemic features: further expansion of the phenotype. Eur J Pediatr 2000; 159 (10) 745-749
77 Happle R, Barbi G, Eckert D, Kennerknecht I. “Cutis tricolor”: congenital hyper and hypopigmented macules associated with a sporadic multisystem birth defect: an unusual example of twin spotting?. J Med Genet 1997; 34 (08) 676-678
78 Ruggieri M, Iannetti P, Pavone L. Delineation of a newly recognized neurocutaneous malformation syndrome with “cutis tricolor”. Am J Med Genet A 2003; 120A (01) 110-116
79 Ruggieri M, Iannetti F, Polizzi A. , et al. Cataracts in three children with a newly recognized neurocutaneous malformation phenotype with “cutis tricolor”. Br J Ophthalmol 2009; 93 (01) 127-128
80 Lionetti E, Pavone P, Kennerknecht I. , et al. Neurological manifestations in individuals with pure cutaneous or syndromic (Ruggieri-Happle syndrome) phenotypes with “cutis tricolor”: a study of 14 cases. Neuropediatrics 2010; 41 (02) 60-65
81 Ruggieri M, Roggini M, Kennerknecht I, Polizzi A, Distefano A, Pavone V. Spectrum of skeletal abnormalities in a complex malformation syndrome with “cutis tricolor” (Ruggieri-Happle syndrome). Acta Paediatr 2011; 100 (01) 121-127
82 Torchia D, Schachner LA, Izakovic J. Cutis tricolor. Cutis 2013; 91 (01) 11-16
83 Ruggieri M, Polizzi A, Schepis C. , et al. Cutis tricolor: a literature review and report of five new cases. Quant Imaging Med Surg 2016; 6 (05) 525-534
84 Happle R, Lenz W. Striation of bones in focal dermal hypoplasia: manifestation of functional mosaicism?. Br J Dermatol 1977; 96 (02) 133-135
85 Jenkins ZA, van Kogelenberg M, Morgan T. , et al. Germline mutations in WTX cause a sclerosing skeletal dysplasia but do not predispose to tumorigenesis. Nat Genet 2009; 41 (01) 95-100
86 Perdu B, de Freitas F, Frints SG. , et al. Osteopathia striata with cranial sclerosis owing to WTX gene defect. J Bone Miner Res 2010; 25 (01) 82-90
87 Witkop Jr CJ. Partial expression of sex-linked recessive amelogenesis imperfecta in females compatible with the Lyon hypothesis. Oral Surg Oral Med Oral Pathol 1967; 23 (02) 174-182
88 Balmer R, Cameron AC, Adès L, Aldred MJ. Enamel defects and Lyonization in focal dermal hypoplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98 (06) 686-691
89 Happle R, Küchle HJ. Sectorial cataract: a possible example of lyonisation. Lancet 1983; 2 (8355): 919-920
90 Koniszewski G, Rott HD. The Lyon effect of the lens: findings in the carriers of X chromosome-linked cataract and in Lowe syndrome [article in German]. Klin Monatsbl Augenheilkd 1985; 187 (06) 525-528
91 Rott HD, Koniszewski G. Analogy of Blaschko lines in the eye [article in French]). J Genet Hum 1987; 35 (01) 19-27
92 Lang GE, Rott HD, Pfeiffer RA. X-linked ocular albinism. Characteristic pattern of affection in female carriers. Ophthalmic Paediatr Genet 1990; 11 (04) 265-271
93 Born G, Grützner P, Hemminger H. Evidence for reduced color vision in carriers of congenital colour vision deficiencies [author's transl [article in German]. Hum Genet 1976; 32 (02) 189-196
94 Rott HD, Lang GE, Huk W, Pfeiffer RA. Hypomelanosis of Ito (incontinentia pigmenti achromians). Ophthalmological evidence for somatic mosaicism. Ophthalmic Paediatr Genet 1990; 11 (04) 273-279
95 Meyer CH, Rodrigues EB, Mennel S, Schmidt JC, Kroll P. Grouped congenital hypertrophy of the retinal pigment epithelium follows developmental patterns of pigmentary mosaicism. Ophthalmology 2005; 112 (05) 841-847
96 Meyer CH, Freyschmidt-Paul P, Happle R, Kroll P. Unilateral linear hyperpigmentation of the skin with ipsilateral sectorial hyperpigmentation of the retina. Am J Med Genet A 2004; 126A (01) 89-92
97 Toberer F, Happle R, Schneiderbauer R. , et al. At first sight or second glance: clinical presentation of mosaic manifestations of autosomal dominant skin disorders - a case series. J Eur Acad Dermatol Venereol 2017; 31 (11) 1912-1915
98 Happle R. The categories of cutaneous mosaicism: A proposed classification. Am J Med Genet A 2016; 170A (02) 452-459